US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 19, 2021

    Walmart Punished In Opioid MDL For Discovery Defiance

    Walmart Inc. intentionally flouted its discovery duties in multidistrict opioid litigation, and the retail giant concocted disingenuous and nonsensical excuses for its failures, according to a new ruling that awarded sanctions and threatened "serious monetary fines" for future violations.

  2. April 08, 2021

    Opioid Judge Withdraws After AbbVie Elevates His Atty Sister

    Despite drugmaker warnings of "harmful and unwarranted" disruption, an Illinois magistrate judge withdrew Thursday from Chicago's bellwether case against drugmakers in multidistrict opioid litigation after the city flagged his sister's new role overseeing thousands of opioid cases for AbbVie Inc.

  3. April 07, 2021

    Opioid MDL Judge Picks New Bellwethers, Denies Retaliating

    The Ohio federal judge supervising multidistrict opioid litigation selected five additional cases Wednesday for bellwether trials against major pharmacy chains, while flatly rejecting assertions that he's punishing the companies for not settling.

  4. April 05, 2021

    Pharmacies Can't Escape More Trials In Opioid MDL

    An Ohio federal judge overseeing multidistrict litigation over the opioid crisis said Monday he won't rethink his order directing parties to tee up another batch of bellwether trials against four major pharmacy chains, reiterating his earlier decision that more bellwethers are necessary to determine the value of the claims.

  5. April 02, 2021

    Pharmacies Take Swipe At Judge Amid Tightening Opioid MDL

    The nation's biggest pharmacy chains, increasingly squeezed by multidistrict opioid litigation as other major drug companies eye the exits, are lashing out with insinuations of judicial bias in a bold bid to avoid choosing between treacherous trials and super-sized settlements.

  6. March 31, 2021

    Oldest Opioid Suit, An MDL Bellwether, Evades Latest Assault

    Seven years after becoming the first city to sue drugmakers over the opioid crisis, Chicago on Wednesday saw its bellwether case in multidistrict litigation survive another flurry of attacks, keeping it on track for a long-awaited trial.

  7. March 30, 2021

    4 Highlights As JPML Gets Earful On McKinsey Opioid Suits

    Plaintiffs attorneys diverged late Tuesday on whether a fast-rising tide of opioid-crisis lawsuits against McKinsey & Co. belongs in new or existing multidistrict litigation, but they found common ground in deriding the consulting giant's quest for an MDL near its New York City headquarters.

  8. March 29, 2021

    Opioid MDL's Tribal Bellwether Dodges Early Drug Co. Attacks

    An Oklahoma federal judge Monday rejected sweeping attacks on one of the biggest cases blaming drug companies for opioid abuse on Native American lands but also signaled that the multidistrict litigation bellwether has potential vulnerabilities.

  9. March 26, 2021

    Rite Aid Balks At Opioid MDL Judge's 'Tons Of Money' Remark

    Rite Aid Corp. on Friday accused the Ohio federal judge supervising multidistrict opioid litigation of adding the pharmacy giant to upcoming bellwether trials based on the mistaken view that it has "tons of money" to pay massive legal bills.

  10. March 25, 2021

    Cherokees Can't Widen Opioid Discovery, Companies Say

    Drug distributors and pharmacies have urged an Oklahoma federal judge to reject the Cherokee Nation's bid for further discovery in its suit over the opioid crisis, saying that allowing discovery outside the tribe's jurisdiction, including in other states, would go far beyond what's been allowed before in opioid litigation.